Thiobutabarbital: Difference between revisions

Jump to navigation Jump to search
WikiBot (talk | contribs)
m Protected "Thiobutabarbital": Protecting pages from unwanted edits ([edit=sysop] (indefinite) [move=sysop] (indefinite))
 
WikiBot (talk | contribs)
m Robot: Automated text replacement (-{{reflist}} +{{reflist|2}}, -<references /> +{{reflist|2}}, -{{WikiDoc Cardiology Network Infobox}} +)
 
Line 30: Line 30:


== References ==
== References ==
<references />
{{reflist|2}}


{{pharma-stub}}
{{pharma-stub}}

Latest revision as of 15:31, 6 September 2012

Thiobutabarbital
File:Thiobutabarbital.svg
Clinical data
SynonymsThiobutabarbital, Inactin, Brevinarcon, 5-sec-Butyl-5-ethyl-2-thiobarbituric acid
Identifiers
CAS Number
PubChem CID
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).
Chemical and physical data
FormulaC10H16N2O2S
Molar mass228.312 g/mol

Thiobutabarbital (Inactin, Brevinarcon) is a short-acting barbiturate derivative invented in the 1950s. It has sedative, anticonvulsant and hypnotic effects, and is still used in veterinary medicine for induction in surgical anaesthesia [1]

References

  1. Rieg T, Richter K, Osswald H, Vallon V. Kidney function in mice: thiobutabarbital versus alpha-chloralose anesthesia. Naunyn Schmiedebergs Archives of Pharmacology. 2004 Oct;370(4):320-3.

Template:Pharma-stub

Template:Barbiturates de:Thiobutabarbital Template:WikiDoc Sources